How can we provide better care for people in their familiar surroundings while at the same time ensuring that the healthcare system is fit for the future? A team in Lucerne is addressing this question in collaboration with researchers from four European countries.

The Zug Institute for Blockchain Research (ZIBR) will officially open its doors on 23 January. All interested parties are warmly invited to attend.

The faculty assembly has elected Professor Manuel Oechslin as the new Dean of the Faculty of Economics and Management at the University of Lucerne. He will start his new role on 1 August 2026.

Grandparents play a vital but often overlooked role when a child is diagnosed with cancer. Findings from the GROKids Project show that supporting them with reliable information and emotional care benefits the entire family.

An international research group has developed guidelines for the future use of artificial intelligence (AI) in the diagnosis and treatment of breast cancer. This marks the third result of the project initiated in Lucerne.

The Swiss Academies of Arts and Sciences (a+) have awarded the Faculty of Law’s "Choice of Law Dataverse" project the National Prize for Open Research Data.

Postdoctoral researcher Ahmed Ajil has been awarded a EUR 1.5 million Starting Grant by the European Research Council (ERC). His five-year project seeks to address critical gaps in counterterrorism research.

Why do people choose a monastic life? What sustains them in it? A new oral history project led by the University of Lucerne explores the lives and identities of Benedictine monks and nuns – and how monastic life has evolved over the past 75 years.

A joint research project by the Lucerne University of Applied Sciences and Arts and the University of Lucerne examines how organisations in Switzerland identify, develop and retain talent. The second phase of the study highlights trends, challenges and future directions in Talent Management (TM).

A study led by the University of Lucerne has found that some antibiotics are associated with almost double the risk of wound infections following surgery. These drugs are often prescribed when an allergy is suspected.